Back to RHHBYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Paroxysmal Nocturnal Hemoglobinuria
View Full LandscapeDrug Information
Target Indication
Paroxysmal Nocturnal Hemoglobinuria
Clinical Trial
NCT04434092Last updated: 2/10/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Folinic Acid, interferon-alphaPhase 3
Rectal Cancer
LHRH AgonistPhase 3
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
emtricitabine/tenofovirPhase 3
HIV Infections
Irinotecan (CPT-11)Phase 3
Colorectal Cancer
Ribavirin "loading" dose givenPhase 3
Hepatitis C
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts